Where it comes from
- Made in
- Beta cells of the pancreatic islets, one molecule for every molecule of insulin
- Sent out by
- With insulin, from the same granules, whenever blood glucose rises
- Acts on
- Kidney
- Peripheral nerves
- Small blood vessels
What it does
- Holds proinsulin in the shape that lets the two insulin chains fold and link
- Signals of its own are reported in nerve and kidney cells, but no settled function and no agreed receptor 1
- Lasts about five times longer in blood than insulin, so it reports the pancreas’s output faithfully
In medicine
- Measured to tell how much insulin a pancreas still makes: low or absent in type 1 diabetes, preserved in type 2
- Tells injected insulin, which carries no C-peptide, from the body’s own in a hypoglycaemia work-up
- Used to decide who needs insulin and who may stop it
Beyond the body’s own use
- Replacement C-peptide was trialled for diabetic nerve damage. In 250 people with type 1 diabetes given a long-acting form weekly for a year, nerve conduction and the clinical neuropathy score did not improve over placebo; only the vibration threshold did, and development stopped 2
- That is as far as the idea has gone, and the missing receptor is the main reason: without one, there is no way to say what a dose should do 1
- It is a measurement, not a treatment. What is asked of it now is how long a pancreas keeps making any insulin after a type 1 diagnosis 1
Sources
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.